Health ❯ Obesity

Treatment

Medications Pharmaceuticals Pharmacology Wegovy GLP-1 Therapies Pharmacotherapy Clinical Trials Weight Loss Injections Weight-Loss Surgery Individualized Approaches Gene Therapy Chronic Disease Weight Loss Behavioral Interventions Investigational Drugs Medication Discontinuation

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

The INHBE-targeting siRNA produced durable Activin E suppression supporting infrequent dosing.

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Tufts Team Designs Experimental Four-Hormone Obesity Drug Aimed at Bigger, Gentler Weight Loss

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Obesity Disrupts Olfactory Pathway That Reduces Hunger in Mice